skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Sponsors

IQVIA
Acceltra_logo_Pharma_Intelligence
Aurobindo
IHP
Pirimal Solutions
Pharmacloud
Pharmawiselogo

Global Generics & Biosimilars Awards 2019

Award Categories & Entry Criteria

Please find below the full list of categories for the Global Generic & Biosimilar Awards.

We also suggest that you include supporting evidence with your entry. This could include:

1. Market data to show commercial success
2. Details of deals done, synergies delivered and integration goals achieved
3. Brief accounts of litigation and other legal action
4. Or responses and testimonals from customers

 

    The activities in question should have taken place between 1 July 2018- 30 June 2019. 
    Choose your category and then click here to create an account and start working on your entry.


    Company of the Year
    Open to any company that generates at least a third, or at least US$250 million, of its annual sales from generics or biosimilars.
    Enter now


    Company of the Year, Americas

    Open to any company that generates at least a third, or at least US$250 million, of its annual sales from generics and biosimilars. Qualification for a region is dependent on the headquarters (not tax domicile) of a company’s generics and/or biosimilars business.
    Enter now


    Company of the Year, Asia-Pacific

    Open to any company that generates at least a third, or at least US$250 million, of its annual sales from generics and biosimilars. Qualification for a region is dependent on the headquarters (not tax domicile) of a company’s generics and/or biosimilars business.
    Enter now


    Company of the Year, EMEA

    Open to any company that generates at least a third, or at least US$250 million, of its annual sales from generics and biosimilars. Qualification for a region is dependent on the headquarters (not tax domicile) of a company’s generics and/or biosimilars business.
    Enter now

    Acquisition of the Year
    Open to any company which has acquired another company that is active in generics and/or biosimilars, or has acquired a portfolio of generic and/or biosimilar products.
    Enter now


    Leader of the Year

    Open to any member of the senior management team of a firm within the generics or biosimilars industries. Judges will want to see how the entered leaders have best applied company values within the business environment – achieving measured and sustainable growth, driving improved performance, delivering shareholder value, implementing robust strategies, engaging staff, demonstrating market knowledge and true customer insight.
    Enter now


    Value Added Medicine Initiative of the Year - NEW
    Entries in this category could include known molecules that are repurposed for new indications, reformulated in a way that adds value for patients, put together in innovative combinations, or which feature added-value packaging or delivery methods.
    Enter now


    Business Development of the Year
    Open to any generics and/or biosimilars alliance, joint venture, distribution agreement, licensing deal or similar that does not involve the acquisition of another company or a portfolio of products.

    Enter now


    API Supplier of the Year

    Open to any company supplying off-patent active pharmaceutical ingredients (APIs) or intermediates.
    Enter now

     

    Biosimilar Initiative of the Year
    Entries may relate to any biosimilar currently marketed, approved or in clinical development, sales and marketing initiatives, distribution agreements or other initiatives aimed at increasing biosimilar usage.
    Enter now


    Regulatory Achievement of the Year
    Awarded to identify excellence in the regulatory sphere. This could include innovative approaches to obtaining marketing authorisations, regulatory milestones for individual companies, or developments that represent a wider breakthrough for the global generics and/or biosimilars industries.
    Enter now

     

    Legal Strategy of the Year
    This category allows generics, biosimilars and value-added medicines firms as well as their partnering law firms to highlight outstanding results from their legal strategy. This could include notable litigation results allowing a competitive advantage or early launch; inventive ways of getting around or invalidating intellectual property; or ways in which legal strategies from different global jurisdictions have been used as a template elsewhere, showing the benefits of a co-ordinated international legal strategy.
    Enter now

     

    Industry Partner of the Year
    Awarded to recognise outstanding achievements by firms or individuals that work alongside generics and biosimilars manufacturers and suppliers. These could include logistics providers, contract-research organisations, contract-manufacturers, law firms and consultants.
    Enter now


    Corporate Social Responsibility (CSR) Initiative of the Year
    Entries could include: company approach to CSR, implementation, engagement plans, training & education programmes, compulsory licensing and humanitarian aid donations.
    Enter now


    Contact us today

    For Sponsorship Opportunities contact:

    Rob Coulson
    Email: rob.coulson@informa.com
    Tel: +44 (0) 7900 658185

    For all other enquiries:
    Natalie Cornwell
    Email: natalie.cornwell@informa.com
    Tel: +44 (0) 7827 993 776